← Open Payments lookup

EDDIE BEAL: Open Payments

NPI 1265644207 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$758 in 27 payments from 10 companies in 2025. Trend: 2023 $1,417 · 2024 $1,576 · 2025 $758

Food & beverage: $758
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$287
E.R. Squibb & Sons, L.L.C.4$184
ABBVIE INC.3$67
Supernus Pharmaceuticals, Inc.3$53
Lundbeck LLC2$40
Otsuka America Pharmaceutical, Inc.2$33
Axsome Therapeutics, Inc.2$33
Novo Nordisk Inc1$25
Takeda Pharmaceuticals U.S.A., Inc.1$18
Teva Pharmaceuticals USA, Inc.1$17

Products named: INGREZZA, COBENFY, VRAYLAR, REXULTI, Qelbree, Auvelity, Ozempic, ABILIFY ASIMTUFII.

Industry payments across GA — which companies pay providers there.